Introduction: Human immunodeficiency virus (HIV) infection is an important public health problem. Even though highly active antiretroviral therapy (HAART) has improved patient survival, there are some important secondary metabolic complications.Objectives: To describe epidemiological features, metabolic alterations, and metabolic syndrome rates in HIV-infected patients receiving HAART, as well as to determine whether there is any statistical association between such alterations and the therapy they are receiving.Material and Method: This is a pilot cross-sectional study carried out between November 2006 and June 2007 in male and female patients between 18 and 40 years of age from the Infectious Disease service of Arzobispo Loayza National Hospital, with a confirmed diagnosis of HIV infection (ELISA + Western Blot), with CD4 cell and viral load counts no more than 6 months ...

Introduction: Human immunodeficiency virus (HIV) infection is an important public health problem. Even though highly active antiretroviral therapy (HAART) has improved patient survival, there are some important secondary metabolic complications.Objectives: To describe epidemiological features, metabolic alterations, and metabolic syndrome rates in HIV-infected patients receiving HAART, as well as to determine whether there is any statistical association between such alterations and the therapy they are receiving.Material and Method: This is a pilot cross-sectional study carried out between November 2006 and June 2007 in male and female patients between 18 and 40 years of age from the Infectious Disease service of Arzobispo Loayza National Hospital, with a confirmed diagnosis of HIV infection (ELISA + Western Blot), with CD4 cell and viral load counts no more than 6 months ...